Trial intelligence / Profile preview

Pre-operative heparin infusion to prevent pulmonary microvascular thrombosis after cardiac surgery

ACTRN12606000328572Phase 2Not yet recruiting

Sponsor
St Vincent's Hospital Melbourne
Start
Aug 2006
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in coronary arteriosclerosis comparing Heparin infusion with Placebo infusion (2 arms). Primary endpoint: Evidence of microvascular thrombosis on lung biopsy. Planned start Aug 2006; status: not yet recruiting.

02

Drugs

heparin
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ACTRN12606000328572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12606000328572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call